These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6129344)

  • 41. Impairment of hepatic drug metabolism in patients with acute viral hepatitis.
    Narang AP; Datta DV; Nath N; Mathur VS
    Eur J Drug Metab Pharmacokinet; 1982; 7(4):255-8. PubMed ID: 7166177
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of enzyme induction on plasma lipids using antipyrine, phenobarbital, and rifampicin.
    Ohnhaus EE; Kirchhof B; Peheim E
    Clin Pharmacol Ther; 1979 May; 25(5 Pt 1):591-7. PubMed ID: 35298
    [No Abstract]   [Full Text] [Related]  

  • 43. Pharmacokinetics of single doses of sulphinpyrazone and its major metabolites in plasma and urine.
    Bradbrook ID; John VA; Morrison PJ; Rogers HJ; Spector RG
    Br J Clin Pharmacol; 1982 Feb; 13(2):177-85. PubMed ID: 7059415
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pharmacokinetics of sulphinpyrazone and its major metabolites after a single dose and during chronic treatment.
    Schlicht F; Staiger C; de Vries J; Gundert-Remy U; Hildebrandt R; Harenberg J; Wang NS; Weber E
    Eur J Clin Pharmacol; 1985; 28(1):97-103. PubMed ID: 3987792
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The effect of intravenous pretreatment with small liposomes on the pharmacokinetics and metabolism of antipyrine in rabbits.
    Badiola N; Al-Angary AN; Halbert GW
    J Pharm Pharmacol; 1992 Apr; 44(4):366-8. PubMed ID: 1355554
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Plasma levels and effects of sulfinpyrazone in patients requiring chronic hemodialysis.
    Bern MM; Cavaliere BM; Lukas G
    J Clin Pharmacol; 1980; 20(2-3):107-16. PubMed ID: 7381028
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The effect of verapamil on antipyrine pharmacokinetics and metabolism in man.
    Bach D; Blevins R; Kerner N; Rubenfire M; Edwards DJ
    Br J Clin Pharmacol; 1986 Jun; 21(6):655-9. PubMed ID: 3741715
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Enzyme induction by phenobarbitone and vitamin K1 disposition in man.
    Park BK; Wilson AC; Kaatz G; Ohnhaus EE
    Br J Clin Pharmacol; 1984 Jul; 18(1):94-7. PubMed ID: 6743493
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Impairment of drug elimination in patients with liver disease.
    Narang AP; Datta DV; Mathur VS
    Int J Clin Pharmacol Ther Toxicol; 1985 Jan; 23(1):28-32. PubMed ID: 3988389
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Induction of hexobarbital and antipyrine metabolism by rifampicin treatment in the pig.
    van den Broek JM; Teunissen MW; Breimer DD
    Drug Metab Dispos; 1981; 9(6):541-4. PubMed ID: 6120813
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Modification of the action of drugs by inhibition of their metabolism].
    Park BK; Breckenridge AM; Ohnhaus EE
    Recenti Prog Med; 1979 Sep; 67(3):313-45. PubMed ID: 42953
    [No Abstract]   [Full Text] [Related]  

  • 52. [Place of gammaglutamyltransferase among the indirect procedures of evaluation of the function of enzymes of drug metabolism (author's transl)].
    Siest G; Ratanasavanh D; Bagrel D; Tazi A; Galteau MM
    Ann Biol Clin (Paris); 1980; 38(1):67-73. PubMed ID: 6103683
    [No Abstract]   [Full Text] [Related]  

  • 53. New metabolites of sulfinpyrazone in man.
    Dieterle W; Faigle JW; Moppert J
    Arzneimittelforschung; 1980; 30(6):989-93. PubMed ID: 7191279
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antipyrine clearance and metabolite formation in patients with alcoholic cirrhosis.
    Teunissen MW; Spoelstra P; Koch CW; Weeda B; van Duyn W; Janssens AR; Breimer DD
    Br J Clin Pharmacol; 1984 Nov; 18(5):707-15. PubMed ID: 6508980
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of long-term phenothiazine treatment on drug metabolism.
    Kolakowska T; Franklin M; Alapin B
    Br J Clin Pharmacol; 1975 Feb; 2(1):25-8. PubMed ID: 1234485
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clopidogrel and drug metabolism: absence of effect on hepatic enzymes in healthy volunteers.
    Pierce CH; Houle JM; Dickinson JP; Kindermans M; Serre-Lacroix E; Kieffer G; Necciari J
    Semin Thromb Hemost; 1999; 25 Suppl 2():35-9. PubMed ID: 10440421
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Rapid normalization of antipyrine oxidation by heme in variegate porphyria.
    Mustajoki P; Himberg JJ; Tokola O; Tenhunen R
    Clin Pharmacol Ther; 1992 Mar; 51(3):320-4. PubMed ID: 1544288
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The effect of roxatidine acetate and cimetidine on hepatic drug clearance assessed by simultaneous administration of three model substrates.
    Tanaka E; Nakamura K
    Br J Clin Pharmacol; 1989 Aug; 28(2):171-4. PubMed ID: 2570603
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of a selective CYP2C9 inhibitor on the pharmacokinetics of nateglinide in healthy subjects.
    Sabia H; Sunkara G; Ligueros-Saylan M; Wang Y; Smith H; McLeod J; Prasad P
    Eur J Clin Pharmacol; 2004 Aug; 60(6):407-12. PubMed ID: 15197517
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Midazolam and cortisol metabolism before and after CYP3A induction in humans.
    Eeckhoudt SL; Desager JP; Robert AR; Leclercq I; Verbeeck RK; Horsmans Y
    Int J Clin Pharmacol Ther; 2001 Jul; 39(7):293-9. PubMed ID: 11471773
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.